E-submission
Search
- Page Path
- HOME > Search
Original Article
- Interleukin-31, Interleukin-31RA, and OSMR Expression Levels in Post-burn Hypertrophic Scars
- Mi Young Lee, Eun Shin, Hyunchul Kim, In Suk Kwak, Younghee Choi
- J Pathol Transl Med. 2018;52(5):307-313. Published online August 16, 2018
- DOI: https://doi.org/10.4132/jptm.2018.08.03
- 6,143 View
- 190 Download
- 9 Web of Science
- 9 Crossref
-
Abstract
PDF - Background
Although several studies have shown the role of interleukin-31 (IL-31) and its receptors in inducing pruritus in certain skin disorders, knowledge of its role in post-burn hypertrophic scars is insufficient. Therefore, the histopathological expression levels of IL-31, IL-31 receptor alpha (IL-31RA), and oncostatin M receptor (OSMR) in post-burn hypertrophic scar tissues were investigated and compared with normal tissue expression levels.
Methods
Samples of hypertrophic scar tissue were obtained from 20 burn patients through punch biopsy. Normal samples were obtained from areas adjacent to the burn injury site of the same patients. Samples were placed in 10% neutral buffered formalin, embedded in paraplast, and processed into serial 5-μm sections. Immunohistochemistry results were semi-quantitatively evaluated for IL-31, IL-31RA, and OSMR. By hematoxylin and eosin staining, epidermal and dermal thickness were assessed with a microscope and digital camera. Intensities were rated on a scale of 1 to 4.
Results
Percentages for IL-31, IL-31RA, and OSMR in the epidermal basal layer cell cytoplasm were significantly greater in the burn scar tissue compared to normal skin, as well as the dermal and epidermal thickness (p < .05). There was a significant difference in IL-31 epidermal basal layer intensity in burn scar tissue compared to normal skin (p < .05). Besides the OSMR basal layer intensity, IL-31 and IL-31RA intensities between the burn scar and normal tissues were not significant. However, correlations were significant, indicating that the greater the infiltration percentage, the higher the intensity (p < .05).
Conclusions
IL-31, IL-31RA, and OSMR expression levels are increased in hypertrophic scars compared with normal tissue. -
Citations
Citations to this article as recorded by
- Pharmacotherapy for Keloids and Hypertrophic Scars
Teruo Murakami, Sadayuki Shigeki
International Journal of Molecular Sciences.2024; 25(9): 4674. CrossRef - Understanding Neural Factors in Burn-related Pruritus and Neuropathic Pain
Dulan A Gunawardena, Edward Stanley, Andrea C Issler-Fisher
Journal of Burn Care & Research.2023; 44(5): 1182. CrossRef - Canine interleukin-31 binds directly to OSMRβ with higher binding affinity than to IL-31RA
Yuxin Zheng, Jing Zhang, Tianling Guo, Jin Cao, Lixian Wang, Jie Zhang, Xuefei Pang, Feng Gao, Hua Sun, Haixia Xiao
3 Biotech.2023;[Epub] CrossRef - Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification
Yuping Zheng, Qingrui Huang, Yanfeng Zhang, Lanxin Geng, Wuqing Wang, Huimin Zhang, Xiang He, Qiannan Li
Frontiers in Immunology.2023;[Epub] CrossRef - Role of burn severity and posttraumatic stress symptoms in the co-occurrence of itch and neuropathic pain after burns: A longitudinal study
N. E. E. Van Loey, A. E. E. de Jong, H. W. C. Hofland, A. I. M. van Laarhoven
Frontiers in Medicine.2022;[Epub] CrossRef - Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
Sonja Ständer, Gil Yosipovitch, Franz J. Legat, Jean-Philippe Lacour, Carle Paul, Joanna Narbutt, Thomas Bieber, Laurent Misery, Andreas Wollenberg, Adam Reich, Faiz Ahmad, Christophe Piketty
New England Journal of Medicine.2020; 382(8): 706. CrossRef - Post-Burn Pruritus
Bo Young Chung, Han Bi Kim, Min Je Jung, Seok Young Kang, In-Suk Kwak, Chun Wook Park, Hye One Kim
International Journal of Molecular Sciences.2020; 21(11): 3880. CrossRef - Novel Analgesics with Peripheral Targets
Cosmin I. Ciotu, Michael J.M. Fischer
Neurotherapeutics.2020; 17(3): 784. CrossRef - Post-Burn Pruritus and Its Management—Current and New Avenues for Treatment
Emilie Fowler, Gil Yosipovitch
Current Trauma Reports.2019; 5(2): 90. CrossRef
- Pharmacotherapy for Keloids and Hypertrophic Scars
First
Prev
